Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company,
today announced fourth quarter and full year fiscal 2023 financial
results for the period ending January 31, 2023.
- Revenue for the fourth quarter of fiscal 2023 was $83.3
million, down 7.7% from $90.2 million in the same period in fiscal
2022. For the fiscal year ending January 31, 2023, revenue was
$337.6 million, up 1.7% from $331.9 million for the fiscal year
ending January 31, 2022.
- Gross margin under U.S. generally accepted accounting
principles (GAAP) for the fourth quarter of fiscal 2023 was 59.6%,
compared with 63.5% for the same period in fiscal 2022. For the
fiscal year ending January 31, 2023, GAAP gross margin was 61.9%,
compared with 62.7% for the fiscal year ending January 31,
2022.
- GAAP net loss for the fourth quarter of fiscal 2023 was $11.1
million, or loss per diluted ordinary share of $0.29, compared with
a GAAP net loss of $9.2 million, or loss per diluted ordinary share
of $0.25, for the same period in fiscal 2022. GAAP net loss for the
fiscal year ending January 31, 2023 was $65.4 million, or loss per
diluted ordinary share of $1.70. This compares with GAAP net loss
of $26.4 million, or loss per diluted ordinary share of $0.72, for
the fiscal year ending January 31, 2022.
Financial results on a non-GAAP basis for the fourth quarter and
full year fiscal 2023 are as follows:
- Gross margin on a non-GAAP basis for the fourth quarter of
fiscal 2023 was 63.5%, compared with 64.8% for the same period in
fiscal 2022. For the fiscal year ending January 31, 2023, non-GAAP
gross margin was 63.9%, compared with 63.4% for the fiscal year
ending January 31, 2022.
- Non-GAAP net income for the fourth quarter of fiscal 2023 was
$8.9 million, or earnings per diluted ordinary share of $0.23. This
compares with non-GAAP net income of $17.9 million, or earnings per
diluted ordinary share of $0.45, for the same period in fiscal
2022. Non-GAAP net income for the fiscal year ending January 31,
2023 was $43.1 million, or earnings per diluted ordinary share of
$1.10. This compares with non-GAAP net income of $62.2 million, or
earnings per diluted ordinary share of $1.61, for the fiscal year
ending January 31, 2022.
Based on information available as of today, Ambarella is
offering the following guidance for the first quarter of fiscal
year 2024, ending April 30, 2023:
- Revenue is expected to be between $60.0 million and $64.0
million
- Gross margin on a non-GAAP basis is expected to be between
62.0% and 64.0%
- Non-GAAP operating expenses are expected to be between $47.0
million and $49.0 million
Ambarella reports gross margin, net income (loss) and earnings
(losses) per share in accordance with GAAP and, additionally, on a
non-GAAP basis. Non-GAAP financial information excludes the impact
of stock-based compensation and acquisition-related costs adjusted
for the associated tax impact, which includes the effect of any
benefits or shortfalls recognized. A reconciliation of the GAAP to
non-GAAP gross margin, net income (loss) and earnings (losses) per
share for the periods presented, as well as a description of the
items excluded from the non-GAAP calculations, is included in the
financial statements portion of this press release.
Total cash, cash equivalents and marketable debt securities on
hand at the end of the fourth quarter of fiscal 2023 was $206.9
million, compared with $199.0 million at the end of the prior
quarter and $171.0 million at the end of the same quarter a year
ago.
“We achieved significant milestones in fiscal 2023 towards our
transformation to an edge AI company. CV3-AD, the first processor
in our 3rd generation edge AI family, was broadly sampled, we
commenced mass production of CV5, our first 5nm SoC, we introduced
our centralized 4D imaging radar, and took important steps towards
commercialization of our software stack IP,” said Fermi Wang,
President and CEO. “Our customers indicate end market demand is
healthy, but we are experiencing a more pronounced slowdown as they
reduce inventory. Our Q1 revenue is expected to be well below end
market consumption, and we currently do not expect these existing
cyclical factors to cause future quarter revenue to decline below
our Q1 guidance.”
Quarterly Conference Call
Ambarella plans to hold a conference call at 4:30 p.m. Eastern
Time / 1:30 p.m. Pacific Time today with Fermi Wang, President and
Chief Executive Officer, and Brian White, Chief Financial Officer,
to discuss the fourth quarter of fiscal year 2023 results. A live
and archived webcast of the call will be available on Ambarella’s
website at http://www.ambarella.com/ for up to 30 days after the
call.
About Ambarella
Ambarella’s products are used in a wide variety of human vision
and edge AI applications, including video security, advanced driver
assistance systems (ADAS), electronic mirror, drive recorder,
driver/cabin monitoring, autonomous driving and robotics
applications. Ambarella’s low-power systems-on-chip (SoCs) offer
high-resolution video compression, advanced image and radar
processing, and powerful deep neural network processing to enable
intelligent perception, fusion and planning. For more information,
please visit www.ambarella.com.
"Safe harbor" statement under the Private Securities
Litigation Reform Act of 1995
This press release contains forward-looking statements that are
not historical facts and often can be identified by terms such as
“outlook,” “projected,” “intends,” “will,” “estimates,”
“anticipates,” “expects,” “believes,” “could,” or similar
expressions, including the guidance for the first quarter of fiscal
year 2024 ending April 30, 2023, and the comments of our CEO
relating to end market demand for products incorporating our
solutions and economic and cyclical headwinds faced by the Company
that may impact the Company’s future revenue, including inventory
management by customers. The achievement or success of the matters
covered by such forward-looking statements involves risks,
uncertainties and assumptions. Our actual results could differ
materially from those predicted or implied and reported results
should not be considered as an indication of our future
performance.
The risks and uncertainties referred to above include, but are
not limited to, risks associated with global health conditions and
associated risk mitigation measures; global economic and political
conditions, including cyclical headwinds in the semiconductor
industry, higher inflation and possible trade tariffs and
restrictions; inventory management by our customers; supply chain
challenges in the semiconductor industry and markets we serve;
revenue being generated from new customers or design wins, neither
of which is assured; the commercial success of our customers’
products; our growth strategy; our ability to anticipate future
market demands and future needs of our customers, particularly for
computer vision applications; our ability to introduce new and
enhanced solutions; our ability to gain customer acceptance of our
new SoC solutions; our ability to develop, and to generate revenue
from, new advanced technologies, such as computer vision
functionality; our ability to retain and expand customer
relationships and to achieve design wins; the expansion of our
current markets and our ability to successfully enter new markets,
such as the OEM automotive and robotics markets; anticipated trends
and challenges, including competition, in the markets in which we
operate; our ability to effectively manage growth; our ability to
retain key employees; and the potential for intellectual property
disputes or other litigation.
Further information on these and other factors that could affect
our financial results is included in the company’s Annual Report on
Form 10-K for our 2022 fiscal year, which is on file with the
Securities and Exchange Commission. Additional information is also
set forth in the company’s quarterly reports on Form 10-Q, annual
reports on Form 10-K and other filings the company makes with the
Securities and Exchange Commission from time to time, copies of
which may be obtained by visiting the Investor Relations portion of
our web site at www.ambarella.com or the SEC's web site at
www.sec.gov. Undue reliance should not be placed on the
forward-looking statements in this release, which are based on
information available to us on the date hereof. The results we
report in our Annual Report on Form 10-K for the fiscal year ending
January 31, 2023 could differ from the preliminary results
announced in this press release.
Ambarella assumes no obligation and does not intend to update
the forward-looking statements made in this press release, except
as required by law.
Non-GAAP Financial Measures
The company has provided in this release non-GAAP financial
information, including non-GAAP gross margin, net income, and
earnings per share, as a supplement to the consolidated financial
statements, which are prepared in accordance with generally
accepted accounting principles ("GAAP"). Management uses these
non-GAAP financial measures internally in analyzing the company’s
financial results to assess operational performance and liquidity.
The company believes that both management and investors benefit
from referring to these non-GAAP financial measures in assessing
its performance and when planning, forecasting and analyzing future
periods. Further, the company believes these non-GAAP financial
measures are useful to investors because they allow for greater
transparency with respect to key financial metrics that the company
uses in making operating decisions and because the company believes
that investors and analysts use them to help assess the health of
its business and for comparison to other companies. Non-GAAP
results are presented for supplemental informational purposes only
for understanding the company’s operating results. The non-GAAP
information should not be considered a substitute for financial
information presented in accordance with GAAP, and may be different
from non-GAAP measures used by other companies.
With respect to its financial results for the fourth quarter of
fiscal year 2023, the company has provided below reconciliations of
its non-GAAP financial measures to its most directly comparable
GAAP financial measures. With respect to the company’s expectations
for the first quarter of fiscal year 2024, a reconciliation of
non-GAAP gross margin and non-GAAP operating expenses guidance to
the closest corresponding GAAP measure is not available without
unreasonable efforts on a forward-looking basis due to the high
variability and low visibility with respect to the charges excluded
from these non-GAAP measures. We expect the variability of the
above charges to have a significant, and potentially unpredictable,
impact on our future GAAP financial results.
AMBARELLA,
INC. |
CONSOLIDATED
STATEMENTS OF OPERATIONS |
(in
thousands, except share and per share data) |
(unaudited) |
|
|
|
|
|
|
|
|
|
Three Months Ended January 31, |
|
Twelve Months Ended January 31, |
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
|
|
|
|
Revenue |
$ |
83,321 |
|
|
$ |
90,229 |
|
|
$ |
337,606 |
|
|
$ |
331,856 |
|
|
|
|
|
|
|
|
|
Cost of
revenue |
|
33,676 |
|
|
|
32,907 |
|
|
|
128,672 |
|
|
|
123,724 |
|
Gross profit |
|
49,645 |
|
|
|
57,322 |
|
|
|
208,934 |
|
|
|
208,132 |
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
Research and development |
|
53,054 |
|
|
|
48,543 |
|
|
|
204,946 |
|
|
|
167,337 |
|
Selling, general and administrative |
|
20,031 |
|
|
|
21,115 |
|
|
|
78,244 |
|
|
|
70,438 |
|
|
|
|
|
|
|
|
|
Total
operating expenses |
|
73,085 |
|
|
|
69,658 |
|
|
|
283,190 |
|
|
|
237,775 |
|
|
|
|
|
|
|
|
|
Loss from
operations |
|
(23,440 |
) |
|
|
(12,336 |
) |
|
|
(74,256 |
) |
|
|
(29,643 |
) |
|
|
|
|
|
|
|
|
Other income
(expense), net |
|
1,825 |
|
|
|
(216 |
) |
|
|
3,318 |
|
|
|
1,002 |
|
|
|
|
|
|
|
|
|
Loss
before income taxes |
|
(21,615 |
) |
|
|
(12,552 |
) |
|
|
(70,938 |
) |
|
|
(28,641 |
) |
|
|
|
|
|
|
|
|
Benefit for
income taxes |
|
(10,510 |
) |
|
|
(3,359 |
) |
|
|
(5,552 |
) |
|
|
(2,230 |
) |
|
|
|
|
|
|
|
|
Net
loss |
$ |
(11,105 |
) |
|
$ |
(9,193 |
) |
|
$ |
(65,386 |
) |
|
$ |
(26,411 |
) |
|
|
|
|
|
|
|
|
Net loss per
share attributable to ordinary shareholders: |
|
|
|
|
|
|
|
Basic |
$ |
(0.29 |
) |
|
$ |
(0.25 |
) |
|
$ |
(1.70 |
) |
|
$ |
(0.72 |
) |
Diluted |
$ |
(0.29 |
) |
|
$ |
(0.25 |
) |
|
$ |
(1.70 |
) |
|
$ |
(0.72 |
) |
Weighted-average shares used to compute net loss per share |
|
|
|
|
|
|
|
attributable to ordinary shareholders: |
|
|
|
|
|
|
|
Basic |
|
38,898,290 |
|
|
|
37,133,454 |
|
|
|
38,363,638 |
|
|
|
36,577,120 |
|
Diluted |
|
38,898,290 |
|
|
|
37,133,454 |
|
|
|
38,363,638 |
|
|
|
36,577,120 |
|
The following tables present details of stock-based compensation
and acquisition-related costs included in each functional line item
in the consolidated statements of operations above:
|
Three Months Ended January 31, |
|
Twelve Months Ended January 31, |
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
|
(unaudited,
in thousands) |
Stock-based
compensation: |
|
|
|
|
|
|
|
Cost of revenue |
$ |
2,526 |
|
|
$ |
416 |
|
|
$ |
3,597 |
|
|
$ |
1,489 |
|
Research and development |
|
17,461 |
|
|
|
18,343 |
|
|
|
71,236 |
|
|
|
54,787 |
|
Selling, general and administrative |
|
9,120 |
|
|
|
8,775 |
|
|
|
36,325 |
|
|
|
31,525 |
|
|
|
|
|
|
|
|
|
Total
stock-based compensation |
$ |
29,107 |
|
|
$ |
27,534 |
|
|
$ |
111,158 |
|
|
$ |
87,801 |
|
|
|
|
|
|
|
|
|
|
Three Months Ended January 31, |
|
Twelve Months Ended January 31, |
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
|
(unaudited,
in thousands) |
Acquisition-related costs: |
|
|
|
|
|
|
|
Cost of revenue |
$ |
757 |
|
|
$ |
757 |
|
|
$ |
3,028 |
|
|
$ |
903 |
|
Research and development |
|
— |
|
|
|
1 |
|
|
|
— |
|
|
|
8 |
|
Selling, general and administrative |
|
488 |
|
|
|
2,220 |
|
|
|
2,066 |
|
|
|
3,821 |
|
|
|
|
|
|
|
|
|
Total
acquisition-related costs |
$ |
1,245 |
|
|
$ |
2,978 |
|
|
$ |
5,094 |
|
|
$ |
4,732 |
|
|
|
|
|
|
|
|
|
The difference between GAAP and non-GAAP gross margin was 3.9%
and 1.3%, or $3.3 million and $1.2 million, for the three months
ending January 31, 2023 and 2022, respectively. The difference
between GAAP and non-GAAP gross margin was 2.0% and 0.7%, or $6.6
million and $2.4 million, for the fiscal years ending January 31,
2023 and 2022, respectively. The differences were due to the effect
of stock-based compensation and the amortization of
acquisition-related costs.
AMBARELLA,
INC. |
RECONCILIATION OF GAAP TO NON-GAAP DILUTED EARNINGS
(LOSSES) PER SHARE |
(in
thousands, except share and per share data) |
|
|
|
|
|
|
|
|
|
Three Months Ended January 31, |
|
Twelve Months Ended January 31, |
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
|
(unaudited) |
GAAP net
loss |
$ |
(11,105 |
) |
|
$ |
(9,193 |
) |
|
$ |
(65,386 |
) |
|
$ |
(26,411 |
) |
|
|
|
|
|
|
|
|
Non-GAAP
adjustments: |
|
|
|
|
|
|
|
Stock-based
compensation expense |
|
29,107 |
|
|
|
27,534 |
|
|
|
111,158 |
|
|
|
87,801 |
|
Acquisition-related costs |
|
1,245 |
|
|
|
2,978 |
|
|
|
5,094 |
|
|
|
4,732 |
|
Income tax
effect |
|
(10,310 |
) |
|
|
(3,445 |
) |
|
|
(7,785 |
) |
|
|
(3,971 |
) |
Non-GAAP net
income |
$ |
8,937 |
|
|
$ |
17,874 |
|
|
$ |
43,081 |
|
|
$ |
62,151 |
|
|
|
|
|
|
|
|
|
GAAP -
diluted weighted average shares |
|
38,898,290 |
|
|
|
37,133,454 |
|
|
|
38,363,638 |
|
|
|
36,577,120 |
|
Non-GAAP -
diluted weighted average shares |
|
39,639,253 |
|
|
|
39,655,416 |
|
|
|
39,135,313 |
|
|
|
38,706,977 |
|
|
|
|
|
|
|
|
|
GAAP -
diluted net loss per share |
$ |
(0.29 |
) |
|
$ |
(0.25 |
) |
|
$ |
(1.70 |
) |
|
$ |
(0.72 |
) |
Non-GAAP
adjustments: |
|
|
|
|
|
|
|
Stock-based
compensation expense |
|
0.75 |
|
|
|
0.74 |
|
|
|
2.90 |
|
|
|
2.40 |
|
Acquisition-related costs |
|
0.03 |
|
|
|
0.08 |
|
|
|
0.13 |
|
|
|
0.13 |
|
Income tax
effect |
|
(0.27 |
) |
|
|
(0.09 |
) |
|
|
(0.20 |
) |
|
|
(0.11 |
) |
Effect of
Non-GAAP - diluted weighted average shares |
|
0.01 |
|
|
|
(0.03 |
) |
|
|
(0.03 |
) |
|
|
(0.09 |
) |
Non-GAAP -
diluted net income per share |
$ |
0.23 |
|
|
$ |
0.45 |
|
|
$ |
1.10 |
|
|
$ |
1.61 |
|
AMBARELLA,
INC. |
CONSOLIDATED
BALANCE SHEETS |
(unaudited,
in thousands) |
|
|
|
|
|
January
31, |
|
January
31, |
|
|
2023 |
|
|
|
2022 |
|
|
|
|
|
ASSETS |
|
|
|
Current
assets: |
|
|
|
Cash and cash equivalents |
$ |
113,541 |
|
|
$ |
171,043 |
|
Marketable debt securities |
|
93,322 |
|
|
|
— |
|
Accounts receivable, net |
|
51,987 |
|
|
|
44,307 |
|
Inventories |
|
40,486 |
|
|
|
45,219 |
|
Restricted cash |
|
8 |
|
|
|
10 |
|
Prepaid expenses and other current assets |
|
5,288 |
|
|
|
6,169 |
|
Total current assets |
|
304,632 |
|
|
|
266,748 |
|
|
|
|
|
Property and
equipment, net |
|
11,814 |
|
|
|
10,134 |
|
Deferred tax
assets, non-current |
|
19,276 |
|
|
|
15,340 |
|
Intangible
assets, net |
|
58,497 |
|
|
|
46,302 |
|
Operating
lease right-of-use assets, net |
|
8,339 |
|
|
|
11,127 |
|
Goodwill |
|
303,625 |
|
|
|
303,625 |
|
Other
non-current assets |
|
4,012 |
|
|
|
4,269 |
|
|
|
|
|
Total assets |
$ |
710,195 |
|
|
$ |
657,545 |
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
|
|
|
Current
liabilities: |
|
|
|
Accounts payable |
|
17,845 |
|
|
|
31,170 |
|
Accrued and other current liabilities |
|
56,655 |
|
|
|
52,064 |
|
Operating lease liabilities, current |
|
3,539 |
|
|
|
3,391 |
|
Income taxes payable |
|
4,112 |
|
|
|
1,245 |
|
Deferred revenue, current |
|
1,311 |
|
|
|
1,414 |
|
Total current liabilities |
|
83,462 |
|
|
|
89,284 |
|
|
|
|
|
Operating
lease liabilities, non-current |
|
5,097 |
|
|
|
8,322 |
|
Other
long-term liabilities |
|
15,548 |
|
|
|
12,763 |
|
|
|
|
|
Total liabilities |
|
104,107 |
|
|
|
110,369 |
|
|
|
|
|
Shareholders' equity: |
|
|
|
Preference shares |
|
— |
|
|
|
— |
|
Ordinary shares |
|
18 |
|
|
|
17 |
|
Additional paid-in capital |
|
572,076 |
|
|
|
447,287 |
|
Accumulated other comprehensive loss |
|
(492 |
) |
|
|
— |
|
Retained earnings |
|
34,486 |
|
|
|
99,872 |
|
Total shareholders’ equity |
|
606,088 |
|
|
|
547,176 |
|
|
|
|
|
Total liabilities and shareholders' equity |
$ |
710,195 |
|
|
$ |
657,545 |
|
Contact:
Louis Gerhardy408.636.2310lgerhardy@ambarella.com
Ambarella (NASDAQ:AMBA)
Historical Stock Chart
From May 2023 to Jun 2023
Ambarella (NASDAQ:AMBA)
Historical Stock Chart
From Jun 2022 to Jun 2023